Medicine

Permanent URI for this communityhttp://repository.kln.ac.lk/handle/123456789/12

This repository contains the published and unpublished research of the Faculty of Medicine by the staff members of the faculty

Browse

Search Results

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka
    (BioMed Central, 2024) Manamperi, N.H.; Edirisinghe, N.M.; Wijesinghe, H.; Pathiraja, L.; Pathirana, N.; Wanasinghe, V.S.; De Silva, C.G.; Abeyewickreme, W.; Karunaweera, N.D.
    BACKGROUND Characterization of the host response in cutaneous leishmaniasis (CL) through proteome profiling has gained limited insights into leishmaniasis research compared to that of the parasite. The primary objective of this study was to comprehensively analyze the proteomic profile of the skin lesions tissues in patients with CL, by mass spectrometry, and subsequent validation of these findings through immunohistochemical methods.METHODS Eight lesion specimens from leishmaniasis-confirmed patients and eight control skin biopsies were processed for proteomic profiling by mass spectrometry. Formalin-fixed paraffin-embedded lesion specimens from thirty patients and six control skin specimens were used for Immunohistochemistry (IHC) staining. Statistical analyses were carried out using SPSS software. The chi-square test was used to assess the association between the degree of staining for each marker and the clinical and pathological features.RESULTS Sixty-seven proteins exhibited significant differential expression between tissues of CL lesions and healthy controls (p < 0.01), representing numerous enriched biological processes within the lesion tissue, as evident by both the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. Among these, the integrated endoplasmic reticulum stress response (IERSR) emerges as a pathway characterized by the up-regulated proteins in CL tissues compared to healthy skin. Expression of endoplasmic reticulum (ER) stress sensors, inositol-requiring enzyme-1 (IRE1), protein kinase RNA-like ER kinase (PERK) and activating transcription factor 6 (ATF6) in lesion tissue was validated by immunohistochemistry.CONCLUSIONS In conclusion, proteomic profiling of skin lesions carried out as a discovery phase study revealed a multitude of probable immunological and pathological mechanisms operating in patients with CL in Sri Lanka, which needs to be further elaborated using more in-depth and targeted investigations. Further research exploring the intricate interplay between ER stress and CL pathophysiology may offer promising avenues for the development of novel diagnostic tools and therapeutic strategies in combating this disease.
  • Thumbnail Image
    Item
    Clinical and histopathological characteristics of cutaneous leishmaniasis in a group of military personnel in Sri Lanka
    (American Society of Tropical Medicine and Hygiene, 2015) Manamperi, N.H.; Fernando, C.S.; Pathirana, A.; Abeyewickreme, W.; de Silva, V.C.; Karunaweera, N.D.
    Cutaneous leishmaniasis (CL) is a newly established vector-borne parasitic disease in Sri Lanka. Military personnel have an occupational risk for CL due to being stationed in endemic areas and exposure to vectors outdoors. This study describes the clinical and histopathological features of CL in a group of military personnel. Thirty five patients with smear positive for Leishmania amastigotes were included, their data analyzed for clinical features and skin biopsies processed routinely for histology, examined at a conference microscope and classified into 4 groups using modified Ridley criteria for Leishmaniasis as: I-parasitized macrophages with variable lymphocytes and plasma cells; II-parasitized macrophages with lymphocytes, plasma cells and ill formed histiocytic granulomata; III-a mixture of macrophages (with or without parasites), lymphocytes, plasma cells and epithelioid granulomata; IV-epithelioid granulomatous response with a few lymphocytes and plasma cells but no amastigotes. Lesions were categorized by duration, as acute (< 6 months) or chronic (> 6 months). Study group composed of all males with a mean age of 32.6 years (range 22-47) and lesion duration of 5.6 months (range 1-24). Number of lesions varied from 1 to 6 with majority (71.4%, n= 25) having a single lesion. Nodular (37.1%, n=13) and nodulo-ulcerative (25.7%, n=9) lesions in upper limbs (68.6%, n=24) was the commonest presentation. Twenty nine (82.9%) of the biopsies were positive also by histology. Twenty two (62.9%) were acute and 13 (37.1%) chronic. Group I, II, III and IV patterns were seen in 14 (40%), 12 (34.3%), 5 (14.3%) and 4 (11.4%) respectively and 9 (40.9%), 9 (40.9%), 2 (9.1%) and 2 (9.1%) of acute lesions and 5 (38.5%), 3 (23.1%), 3 (23.1%) and 2 (15.4%) of chronic lesions respectively. Necrosis was not seen in any of the lesions. Majority in this group of military personnel with CL had single lesions affecting the upper limbs and sought treatment within 2 years of appearance of lesions. The histological picture varied from diffuse infiltration of parasitized macrophages admixed with chronic inflammatory cells to ill-formed histiocytic granulomata.
  • Thumbnail Image
    Item
    In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani
    (Oxford, Wiley, 2017) Manamperi, N.H.; Oghumu, S.; Pathirana, N.; de Silva, V.C.; Abeyewickreme, W.; Satoskar, A.R.; Karunaweera, N.D.
    INTRODUCTION: Cutaneous leishmaniasis in Sri Lanka is a newly established parasitic disease caused by the usually visceralizing Leishmania donovani. Skin lesions manifest as non-itchy, non-tender papules, nodules or ulcers. In situ cytokine expression provides clues for immunopathogenesis of this localized form of disease. METHODS: Skin biopsies from 58 patients were analyzed for histological appearance and in situ cytokine expression of T- helper 1 (Th1) and T- helper 2 (Th2) cytokines, namely interferon (IFN)-γ, interleukin (IL)-12A, tumor necrosis factor (TNF)-α, IL-4 and IL-10 by real-time RT- PCR. RESULTS: Significant up regulation of the Th1 cytokine IFN-γ and down regulation of the Th2 cytokine IL-4 was seen in patients compared to healthy controls. Significantly elevated tissue expression of IFN-γ and TNF-α was seen in lesions that presented later than 6 months from the time of onset, while IL-4 expression was more prominent in lesions that responded poorly to antimony therapy. CONCLUSION: A prominent Th1 response appears to support resolving of lesions, whereas a Th2 biased milieu tends to favor poor responsiveness to antimony and delayed lesion healing in L. donovani infections in Sri Lanka. This article is protected by copyright. All rights reserved.
  • Thumbnail Image
    Item
    Randomized placebo-controlled trial of the efficacy of mebendazole polymorphs in the treatment of hookworm infections
    (American Society of Tropical Medicine and Hygiene, 2013) Gunawardena, N.K.; Kumarendran, B.; Manamperi, N.H.; Senarathna, B.P.; Silva, M.; Pathmeswaran, A.; de Silva, N.R.
    Mebendazole has three polymorphic forms, identified as A, B and C. It has been suggested that unlike polymorph C, A is ineffective in the treatment of hookworm and whipworm infections. A randomized doubleblind, placebo-controlled trial was carried out to compare the efficacy of single dose 500 mg tablets of pure mebendazole Polymorph C with those containing a 1:1 mixture of Polymorphs A and C, for the treatment of hookworm infections. All eligible individuals living in 219 households were recruited after obtaining written, informed consent. A single fecal sample was obtained and examined the same day, using the Kato-Katz technique for intestinal nematode infections. Those who were found infected with hookworms were randomized to one of three treatment arms and requested to provide a second faecal sample 10 - 14 days after treatment. This was examined in the same manner as the first. A total of 892 individuals were recruited; 601 provided fecal samples; 214 were found positive for hookworm; 70, 74 and 70 individuals were randomized to treatment arms A (mixture of polymorphs A and C), B (pure polymorph C) and C (placebo) respectively. Follow-up samples were provided by 53, 48 and 49 persons respectively in each treatment arm. The cure rates in the three treatment arms were 28.3%, 18.8% and 16.3% respectively; they were not significantly different from one another. Comparison of fecal egg count reductions (FECR) in the 3 treatment arms (86.1%, 84.5% and -6.6% in Arms A, B and C respectively) showed that both mebendazole formulations performed significantly better than placebo, but there was no statistically significant difference between FECR with the two drug formulations. It is concluded that a single 500mg dose of mebendazole, either as Polymorph C alone, or as a mixture of Polymorphs A and C, has little efficacy in curing hookworm infections. However, both formulations were significantly better than placebo in reducing the intensity of infection, with no statistically significant difference between the two formulations.
  • Thumbnail Image
    Item
    Correlation of clinical presentation and laboratory confirmation of dengue patients
    (Sri Lanka Association for the Advancement of Science, 2010) Manamperi, N.H.; Athapaththu, A.M.M.H.; Premawansa, V.; Wellawaththage, C.; Jayarathna, T.D.S.S.; Abeyewickreme, W.; Hapugoda, M.D.
    Dengue is one of the most important arthropod-borne diseases in the world and it has become a very important disease in Sri Lanka, today. In Sri Lanka, diagnosis of dengue depends mainly on clinical signs and symptoms. Only a few suspected patients are confirmed by laboratory assays based on aetiological agents. The objective of this study was to determine the correlation between clinical presentation and laboratory confirmation of dengue patients. Acute serum samples (n=100) collected from patients clinically suspected of having dengue fever ("'ª-"ý¦> 5 days) warded at the North Colombo Teaching Hospital, Ragama were used for the present study. Serum samples were collected after obtaining informed written consent frompatients and samples were tested by RT-PCR which has high sensitivity (10 FFU/reaction) and specificity. Final diagnosis as dengue or non-dengue was assigned based on the results of RT-PCR assay. Differences in clinical and laboratory data were analyzed in dengue and non dengue patients. Chi-square test was used for comparison of data. The proportion of laboratory confirmed dengue patients were 56% (56/100). Mean platelet count and PCV in laboratory confirmed dengue patients were 60 269/mm 3 (range 3000-306000) and 41% (range 27-61%) and in non dengue patients were 106 318/mm 3 (range 5000-290000) and 41.6% (range 29-53%). Based on WHO criteria for diagnosis of dengue, heada (48/56 vs 41/44, ÝÖ 2 =0.7, p=0.38), retro-orbital pain (30/56 vs 14/44, ÝÖ 2 =3.8, p=0.04), limb pain (51/56 vs 30/44, ÝÖ 2 =7, p=0.00) and external bleeding (29/56 vs 4/44, ÝÖ 2 =18, p=0.00) showed significant association with dengue. Neck pain (10/56 vs 09/44, ÝÖ 2 =0.01, p=0.94), and lymphadenopathy (3/56 vs 02/44, ÝÖ 2 =0.08, p=0.78) did not show significant association with dengue. The infection was confirmed as dengue fever in 11% (6/56) and dengue hemorrhagic fever in 89% (50/56) based on WHO criteria. Surveillance based on clinical diagnosis may result in over estimation of the disease as clinical diagnosis is not specific enough. Laboratory confirmation of dengue suspected patients is important to measure the real incidence of the disease which leads implementation of control measures. Further, thisis important for efficient management of patients.Acknowledgements: Financial and technical assistance from the International Centre for Genetic Engineering and Biotechnology (ICGEB CRP/ SRI08-02) and International Atomic Energy Agency (IAEA SRI 5/042)
All items in this Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated. No item in the repository may be reproduced for commercial or resale purposes.